Datasets:
sruthiselvakumar
/
dataset

Dataset card Data Studio Files
xet
 Community
text
stringlengths
0
146
required balloon dilation or
stenting of the bile ducts.
Biliary tract sclerosis or
obstruction as a
consequence of biliary
surgery, gall stone
disease, infection,
inflammatory bowel
disease or other
secondary precipitants is
excluded.
Cardiac Defibrillator
Insertion
Insertion of a permanent
cardiac defibrillator as a
result of cardiac
arrhythmia which cannot
be treated via any other
method. The surgical
procedure must be
certified to be absolutely
necessary by a specialist
in the relevant field.
Early Cardiomyopathy
The unequivocal
diagnosis of
cardiomyopathy which has
resulted in the presence of
permanent physical
impairments to at least
Class III of the New York
Heart Association (NYHA)
classification of Cardiac
Impairment.
The diagnosis must be
confirmed by a specialist
in the relevant field.
Cardiomyopathy that is
directly related to alcohol
misuse is excluded.
The NYHA Classification
of Cardiac Impairment
(Source: “Current Medical
Advanced Stage1
Fulminant Hepatitis
A submassive to massive
necrosis of the liver by the
Hepatitis virus, leading
precipitously to liver
failure.
This diagnosis must be
supported by all of the
following:
• Rapid decreasing of
liver size as confirmed
by abdominal
ultrasound;
• Necrosis involving entire
lobules, leaving only a
collapsed reticular
framework;
• Rapid deterioration of
liver function tests;
• Deepening jaundice;
and
• Hepatic
encephalopathy.
Heart Attack of Specified
Severity
Death of heart muscle due
to ischaemia, that is
evident by at least three of
the following criteria
proving the occurrence of
a new heart attack:
• History of typical chest
pain;
• New characteristic
electrocardiographic
changes; with the
development of any of
the following: ST
elevation or depression,
T wave inversion,
pathological Q waves or
left bundle branch block;
• Elevation of the cardiac
biomarkers, inclusive of
CKMB above the
generally accepted
normal laboratory levels
or Cardiac Troponin T or
I at 0.5ng/ml and above;
• Imaging evidence of new
loss of viable
myocardium or new
regional wall motion
abnormality. The